The AETHERA trial: Results of a randomized, double-blind, placebo-controlled phase 3 study of brentuximab vedotin in the treatment of patients at risk of progression following autologous stem cell transplant for Hodgkin lymphoma Meeting Abstract
| Authors: | Moskowitz, C. H.; Nadamanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A. I.; Stiff, P. J.; Gianni, A. M.; Carella, A. M.; Osmanov, D.; Bachanova, V.; Sweetenham, J.; Sureda, A.; Huebner, D.; Larsen, E. K.; Hunder, N. N. H.; Walewski, J. |
| Abstract Title: | The AETHERA trial: Results of a randomized, double-blind, placebo-controlled phase 3 study of brentuximab vedotin in the treatment of patients at risk of progression following autologous stem cell transplant for Hodgkin lymphoma |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349233808135 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.673.673 |
| Notes: | Meeting Abstract: 673 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
